Danqi Jiaonang is a traditional Chinese medicine preparation containing a mixture of 14 herbal and plant extracts. It was initially developed by the First Teaching Hospital of Tianjin in China.
Danqi Jiaonang is approved and marketed in Singapore under the brand name NeuroAid for "functional and neurological deficits from cerebral infarction" . NeuroAid was registered as a Chinese proprietary medicine in Singapore in July 2006.
NeuroAid/Danqi Jiaonang is currently being studied at the acute stage of stroke, in a clinical trial conducted by , an international partnership of Key Opinion Leaders in stroke.
The main herbal and natural extracts contained in Danqi Jiaonang are Radix Astragali, Radix Salviae miltiorrhizae, Radix Paeoniae rubra, Rhizoma chuanxiong, Radix notoginseng, Cortex moutan, Lignum Dalbergiae odoriferae, Radix polygalae, and Rhizoma Acori tatarinowii.